Related Experiment Video
Updated: Mar 15, 2026

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Improving pediatric Inflammatory Bowel Disease (IBD) follow-up
Dana Dykes1, Elizabeth Williams1, Peter Margolis1
1Cincinnati Children's Hospital Medical Center, USA.
Telemedicine improves pediatric Inflammatory Bowel Disease (IBD) care by increasing follow-up rates and electronic communication, enhancing access without compromising quality. This novel approach offers cost savings and better patient outcomes.
Area of Science:
- Pediatric Gastroenterology
- Health Services Research
- Digital Health
Background:
- Standardized Inflammatory Bowel Disease (IBD) care via the ImproveCareNow (ICN) Network has improved pediatric outcomes, but progress has plateaued.
- Current ICN guidelines recommend biannual health supervision visits, yet gaps exist in timely follow-up, especially after disease flares or interventions.
- Telemedicine offers a potential solution to address these care gaps in pediatric IBD management, despite limited prior use.
Purpose of the Study:
- To implement and evaluate a multi-step telemedicine approach for pediatric IBD follow-up care.
- To improve timely reassessment of patients with active disease and enhance routine follow-up scheduling.
- To assess the impact of telemedicine on patient access, care quality, and resource utilization.
Main Methods:
- Utilized the Plan-Do-Study-Act (PDSA) model for improvement.
- Implemented a pilot program offering e-visits and e-messaging for pediatric IBD patients.
- Tracked key metrics including follow-up completion rates, e-visit/e-messaging volume, patient portal adoption, and adverse events.
Main Results:
- Patient portal adoption increased from 20% to 70% median within six months.
- E-messaging use grew from 5 to 76 messages/month, and 32 e-visits replaced traditional appointments.
- Telemedicine effectively managed medications, nutrition, and disease activity, with no increase in unplanned visits or emergency department encounters.
Conclusions:
- Telemedicine, including e-visits and e-messaging, successfully enhanced access and care delivery for pediatric IBD patients.
- This novel approach maintained care standards, improved patient convenience by enabling home-based visits, and demonstrated cost-effectiveness.
- Continued use of telemedicine in pediatric IBD is anticipated to improve remission rates and patient-reported outcomes through timely treatment adjustments.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...